Infectious Diseases
General Medicine · Topic 26
Source: NMC CBME Curriculum 2024 · Volume II · General Medicine · Topic 26 · combined PDF page 318
Practice questions
- A hospital committee is reviewing the stated objectives of the 2026 Swiss recommendations for Clostridioides difficile infection. Which set best matches their intended scope?
- Which description best characterizes the development and intended use of the 2026 Swiss CDI recommendations?
- An adult outpatient with mild-to-moderate COVID-19 is being considered for antiviral treatment. Which group contains the three agents named in the updated IDSA antiviral guideline?
- A clinician is checking whether a patient falls within the population explicitly addressed by the 2025 IDSA antiviral update. Which patient description most closely fits its stated scope?
- A hospitalized adult with severe COVID-19 requires an immunomodulator, and the team is choosing between baricitinib and tocilizumab. Which statement accurately describes the relevant IDSA update?
- A district clinic is choosing a diagnostic approach for infectious diseases where rapid results may support early screening and surveillance. Which feature most directly characterizes point-of-care testing as described in the supplied review?
- A team is evaluating a new infectious-disease POCT assay before field deployment. Which set consists entirely of performance or implementation indicators highlighted in the review?
- Which group contains only technology areas included in the review of infectious-disease POCT innovations?
- A health system plans to introduce infectious-disease POCT in a resource-limited region. Which implementation plan best reflects the review's recommendations?
- A public-health report describes a reduction in invasive pneumococcal disease during the COVID-19 pandemic. Which explanation is most consistent with the supplied consensus statement?
- After relaxation of pandemic restrictions, a region experiences a resurgence of invasive pneumococcal disease. Which combination of factors is identified in the regional consensus as contributing to this pattern?
- A regional pneumococcal prevention plan is being revised after vaccination disruptions. Which action best aligns with the consensus statement's approach to sustaining herd protection?
- A surveillance report finds increasing invasive pneumococcal disease caused by serotypes not included in currently used vaccines. Which interpretation is most consistent with the consensus statement?
- Which additional epidemiologic relationship does the consensus statement identify as relevant to post-pandemic invasive pneumococcal disease?
- In research on an emerging high-consequence infectious disease, what major scientific contribution can autopsy provide, according to the supplied review?
- A biosafety officer compares published autopsy guidance for high-consequence pathogens. Which statement best reflects the review's comparison of BSL-3 and BSL-4 guidance?
- For BSL-4-level high-consequence infectious disease, what does the review say current recommendations are limited to in the absence of official procedural autopsy guidance?
- Which set lists functions attributed to glycans in infectious disease by the supplied review?
- A researcher finds that two glycan structures with similar composition behave differently in an infection assay. Which structural issue highlighted in the review can help explain the challenge of glycan analysis?
- A laboratory is assembling data sources for glycan-centered infectious-disease research. Which set of analytical platforms is listed in the supplied glycoanalysis review?
- A group is selecting machine-learning tasks for an infectious-disease glycomics project. Which task combination is specifically described in the review?
- Which statement about the AI models mentioned in the glycoanalysis review is accurate?
- An AI glycomics model performs inconsistently across datasets. Which set of limitations identified in the review most directly explains why translation can be difficult?
- A review of oral infectious diseases identifies the core pathogenic mechanism associated with antimicrobial resistance in these conditions. Which mechanism is highlighted?
- Traditional therapies and biomaterials for oral biofilm-associated infection are being reviewed for limitations. Which combination is identified in the systematic review?
- Which sequence best represents the range of roles attributed to AI-driven biomaterials for microbiome-associated oral infectious diseases in the systematic review?